Build2 publishersIndependently confirmed3 min readPublished
Unitree's 8,000x book is now the comparable every humanoid banker will quote
Shanghai priced the first mainland humanoid listing at more than seven times its offer. The benchmark it sets was built on robot dogs sold to universities.
The Engineer · Build desk

What happened
- Unitree's shares rose more than 600 percent on their first day of trading on Shanghai's STAR Market.
- The Hangzhou manufacturer raised 6.1 billion yuan, about $905 million, in the offering.
- Applications outnumbered the shares on offer by more than 8,000 times, a record for the STAR board.
Compiled by The EngineerSomething wrong?How this is made
Why it matters
- precedent Every humanoid maker still raising money now has a mainland print and a subscription ratio to put in front of investors, set before industrial demand exists.
- exposure A listed Chinese share price is now geared to overseas revenue that US export and import policy has already touched, so Washington moves the quote.
- contradiction Counterpoint treats the listing as the sector's reference point while Morningstar says wide industrial use is still some way off; the debut price only holds on the first reading.
- decision Unitree must convert lab and campus demand into factory orders while reporting to public shareholders, with the proceeds already committed to capacity.
A benchmark is only worth what it is a benchmark for, so it is worth being precise about the business sitting under the price. Unitree booked nearly 1.7 billion yuan ($252m) of 2025 revenue and 278 million yuan ($41m) of net profit [6][7], a net margin near 16 percent [21], in a segment where profitability is the exception [7]. About 42 percent of that revenue came from four-legged machines, the robot dogs [11]. Industrial applications accounted for under a tenth of sales through the first three quarters, and the main buyers were research and education institutions [8].
Put the delivery figure against the revenue mix and the unit economics come out modest. More than 5,500 humanoids shipped worldwide last year [12]; the non-quadruped 58 percent of revenue spread across them is roughly 179,000 yuan, near $27,000, per humanoid [22]. That is a ceiling rather than an average, because the same 58 percent carries everything else the company sells.
The offer raised 6.1 billion yuan, about 3.6 times last year's revenue [2][19], and the market then paid at least seven times the offer price on day one [1][20]. The subscription ratio is the number that will travel furthest. Taken at face value against the whole deal, cover of more than 8,000 times [10] implies something on the order of 48.8 trillion yuan, about $7.2 trillion, of applications chasing $905m of stock [24]. The report does not say whether the ratio covers the full offering or the retail tranche, so read it as an order of magnitude rather than a settlement figure.
This is the material Agibot's bankers will be working with in Hong Kong [4]. Ethan Qi of Counterpoint Research expects the listing to act as a reference point for the IPOs now in preparation [5], and it will, because until this week there was nothing on the mainland to point at [3]. UBTECH and Dobot have Hong Kong prints [4]; neither of those is a mainland retail order book with a exchange record attached [10].
The counter-argument is in the same filing. Morningstar's Kangyuxiao Li says the step from demonstrations and early deployments to wide industrial use will take time [9], and Unitree's own sales mix agrees with him [8]. More than 40 percent of revenue comes from outside China [13], which is also the part Washington can reach: Unitree was added to the US list of Chinese military-linked firms in June and barred from Pentagon business [14], and last month the US banned imports of new humanoid and quadruped robots from foreign makers on national security grounds [15]. The prospectus concedes that further restrictions could hold back overseas sales growth [16]. Proceeds are earmarked for embodied AI models, robotics hardware and manufacturing capacity, alongside research work with Nvidia [17]. The new Superman model is quoted at a two-metre jump and 12.66 metres per second [18]; a specification is not an order. Chinese manufacturers already outsell Tesla, Figure AI and Boston Dynamics by volume [23], which is why the comparable now sits in Shanghai and not anywhere else.
What to watch
- Whether the debut premium holds through the first lock-up expiry, and where the shares trade when Agibot sets its Hong Kong price range.
- The industrial share of sales in Unitree's first reported period as a listed company, measured against the sub-10 percent figure in the prospectus.
- Any widening of the US import ban or additions to the military-linked list, and what that does to the 40-percent-plus overseas revenue base.
Clarity's read
What the record supports and how the coverage leans. The claims behind it follow.
Reality
- Evidence64
- Adoption34
- Hype gap+52
- Incentives72
- Confidence66
Claim ledger
Ranked by verification strength, evidence, and original report placement.
- [1]
Shares in China's Unitree, the world's largest humanoid robot maker by sales volume, rose more than 600% on their debut day on the Shanghai exchange.
- [2]
The Hangzhou-based manufacturer raised 6.1 billion yuan, or $905 million, in its initial public offering.
- [3]
Unitree is the first humanoid robot maker whose shares have begun trading on a mainland Chinese exchange.
- [4]
Other Chinese companies in the field, including UBTECH and Dobot, are listed on the Hong Kong stock exchange, and Agibot is preparing an IPO in Hong Kong.
- [5]
Ethan Qi of Counterpoint Research called the Unitree IPO a key milestone for the humanoid industry and said it could serve as a reference point for other IPOs in preparation.
ReportedSupportedSource: Ethan Qi, Counterpoint Research2 sources— create a free account to open themView cited source - [6]
Unitree's prospectus reports almost 1.7 billion yuan, or $252 million, of 2025 revenue, more than a tenfold increase over two years.
- [7]
Net profit was 278 million yuan, or $41 million, making Unitree one of the few profitable companies in the humanoid robot segment.
- [8]
In the first three quarters of the year, industrial use accounted for less than 10% of sales, and the main buyers remained research and education institutions.
- [9]
Kangyuxiao Li of Morningstar said Unitree has shown strong technology and commercial potential, but the transition from demonstrations and early deployments to broad industrial use will take time.
ReportedSupportedSource: Kangyuxiao Li, Morningstar2 sources— create a free account to open themView cited source - [10]
Applications to buy shares exceeded the stock on offer by more than 8,000 times, a record for the STAR Market technology board, often described as China's Nasdaq equivalent.
- [11]
Approximately 42% of Unitree's revenue came from sales of four-legged robots, or robot dogs.
- [12]
More than 5,500 humanoid robots were delivered worldwide by Unitree in 2025.
- [13]
Unitree earns more than 40% of its revenue in overseas markets.
- [14]
In June, Unitree was added to a US list of Chinese firms linked to the military and was subsequently barred from doing business with the Pentagon.
- [15]
Last month Washington additionally banned imports of new humanoid and four-legged robots from foreign manufacturers, citing national security risks.
- [16]
In its prospectus Unitree acknowledged that further US restrictions could restrain growth in overseas sales and hurt its financial results.
- [17]
Unitree intends to use the IPO proceeds to build embodied artificial intelligence models, develop robotics hardware and expand manufacturing capacity, and it works with Nvidia on research projects aimed at strengthening its robots' software.
- [18]
On Monday the company presented a new humanoid robot called Superman, which Unitree says can jump up to two metres and move at up to 12.66 metres per second.
- [19]
The IPO raise equalled roughly 3.6 times Unitree's 2025 revenue.
- [20]
A first-day gain of more than 600% means the market paid at least seven times the offer price.
- [21]
Unitree's 2025 net margin was about 16 percent.
- [22]
Non-quadruped revenue divided by humanoid deliveries implies at most about 179,000 yuan (roughly $27,000) of revenue per humanoid robot shipped in 2025; it is a ceiling because the same revenue line covers other products.
- [23]
Chinese manufacturers have already overtaken Tesla, Figure AI and Boston Dynamics in global humanoid robot sales volume.
- [24]
Cover of more than 8,000 times applied to the full offering implies applications on the order of 48.8 trillion yuan, about $7.2 trillion, against $905 million of stock; the source does not specify whether the ratio covers the whole deal or one tranche.
Sources
2 independent publishers whose own reporting we read for this story.
- mezha.netАкції виробника гуманоїдних роботів Unitree злетіли більш ніж на 600% після IPO
1 article · August 22, 2026
- the-decoder.comChina now has its own AI circular financing scheme
1 article · August 20, 2026
Topics and entities
Follow any of these and your For You feed starts watching them — no settings page required.
Topics
- Humanoid RoboticsFollow
- China Tech ListingsFollow
- Industrial Automation EconomicsFollow
- Embodied AIFollow
- Circular Demand and FinancingFollow
- Export Controls and Procurement BansFollow
Entities
- UnitreeFollow
- DeepSeekFollow
- AgibotFollow
- TeslaFollow
- UBTechFollow
- NvidiaFollow
- Jensen HuangFollow
- Interact AnalysisFollow
- Ethan QiFollow
- DobotFollow
- Wang XingxingFollow
- Boston DynamicsFollow
- Vey-Sern LingFollow
- Poe ZhaoFollow
- MorningstarFollow
- Kangyuxiao LiFollow
- Figure AIFollow
- Counterpoint ResearchFollow
- Unitree 'Superman' humanoidFollow
- Marco WangFollow
- Union Bancaire PrivéeFollow
- LejuFollow
- Shanghai STAR MarketFollow